Answers are grounded in this paper and cite their sources.
Demonstrates that zwitterionic modifications improve targeting and reduce off-target binding in PSMA ligands, suggesting better drug design.
Off-target tissue retention is a serious limitation for prostate-specific membrane antigen (PSMA)-targeted drugs. This study addresses key questions regarding the role of zwitterionic modifications in PSMA-ligand design for tissue distribution. A series of fluorescent PSMA-ligands was synthesized and evaluated with respect to PSMA-binding, tumor uptake, and biodistribution in cell experiments and in mice. The data revealed that the introduction of two zwitterionic groups into the linker domain of the PSMA-specific conjugates was particularly advantageous. The resulting compound 10 combined high and specific PSMA-binding affinity (IC₅₀ = 4.39 ± 1.69 nM) and good uptake in tumor cells and tumor xenografts with extremely low off-target tissue retention. A major practical advantage of this strategy is its simple synthetic realization using solid-phase peptide synthesis with commercial building blocks and their modification using click-chemistry. Zwitterionization is therefore easily transferable to other targeting vectors and alternative effector molecules, for example in radiopharmaceuticals.
No takes yet. Share an insight, caveat, or question.
Spickschen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: